We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Accelerating Cancer Immune Cell Therapies
Whitepaper

Accelerating Cancer Immune Cell Therapies

Accelerating Cancer Immune Cell Therapies
Whitepaper

Accelerating Cancer Immune Cell Therapies

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life. Cell therapies, including chimeric antigen receptor (CAR) T-cell therapy, are emerging as promising treatments, especially for hematological malignancies. However, many challenges remain in the development of this emerging class of therapeutics, from deepening responses in blood-based tumors to expanding efficacy in solid tumors.

Download this whitepaper to learn more about:

  • The mechanisms behind response
  • Resistance and toxicity to cell therapies
  • Identifying key biomarkers
Advertisement